NCT02890979View on ClinicalTrials.gov

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 3, 2016

Primary Completion Date

October 10, 2017

Study Completion Date

October 10, 2017

Conditions
Barrett EsophagusDysplasiaEsophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaGastroesophageal Reflux DiseaseMetaplasia
Interventions
OTHER

Cytology Specimen Collection Procedure

Undergo cytology specimen collection procedure using a swallowable sponge cell sampling device

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

DEVICE

Swallowable Sponge Cell Sampling Device

Undergo cytology specimen collection procedure using a swallowable sponge cell sampling device

Trial Locations (1)

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER

NCT02890979 - Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease | Biotech Hunter | Biotech Hunter